The use of molecular markers in the diagnosis of colorectal cancer screening

Digestive Diseases

Volumn 28, Issue 4-5, 2010, Pages 625-628

  Schmid, Gerald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer screening; Colorectal cancer; Fecal occult blood assay; Molecular markers

Indexed keywords

DNA; RNA; VIMENTIN;

CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; DNA ISOLATION; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METHYLATION; NUCLEOTIDE SEQUENCE; OCCULT BLOOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; EARLY DETECTION OF CANCER; GENOMIC INSTABILITY; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649350789     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320064     Document Type: Conference Paper

References (26)

1. Jema l A, Siegel R, Wa rd E, et al. : Canc er s t at is-tics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
2. Markowitz SD, Dawson DM, Willis J, Will-son JK: Focus on colon cancer. Cancer Cell 2002; 1:233-236.
3. Kinzler KW, Vogelstein B: Colorectal Tumors. The Genetic Basis of Human Cancer, ed 2. New York, McGraw-Hill, 2002, pp 583- 612.
4. Markowitz SD, Bertagnolli MM: Molecular origins of cancer: molecular basis of colorec-ta l cancer. N Engl J Med 2009; 361: 2449-2460.
5. Hundt S, Haug U, Brenner H: Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomark-ers Prev 2007; 1 6 : 19 35 -19 53.
6. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE: Noninvasive testing for colorec-tal cancer: a review. Am J Gastroenterol 2005; 10 0 : 1393-1403.
7. Osborn NK, Ahlquist DA: Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005; 128:192-206.
8. Loganayagam A: Faecal screening of colorec-tal cancer. Int J Clin Pract 2008; 62: 454-459.
9. Haug U, Hundt S, Brenner H: Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and compar i son w it h qua l it at ive test s. A m J Ga s-troenterol 2010; 105:682-690.
10. Hundt S, Haug U, Brenner H: Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009; 150:162-169.
11. Ahlquist DA, Sargent DJ, Loprinzi CL, et al: Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008; 149:441-450, W481.
12. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714.
13. Zou H, Taylor WR, Harrington JJ, et al: High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt cur ve assay. Gastroenterology 2009; 136: 459-470.
14. Miesfeld R, Krystal M, Arnheim N: A member of a new repeated sequence family which is conserved throughout eucaryotic evolution is found between the human delta and beta globin genes. Nucleic Acids Res 1981; 9: 5931-5947.
15. Hamada H, Petrino MG, Kakunaga T: A novel repeated element with Z-DNA-forming potential is widely found in evolutionarily diverse eukaryotic genomes. Proc Natl Acad Sci USA 1982; 79: 6465-6469.
16. Tautz D, Renz M: Simple sequences are ubiquitous repetitive components of eukaryotic genomes. Nucleic Acids Res 1984; 12:4127-4138.
17. Farber RA, Petes TD, Dominska M, Hudgens SS, Liskay RM: Instability of simple sequence repeats in a mammalian cell line. Hum Mol Genet 1994; 3:253-256.
18. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the de termination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
19. Boland CR, Shike M: Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. Gas-troenterology 2010; 138: 2197, e2191-e2197.
20. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR: Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000; 2:20-28.
21. Ahlquist DA, Skoletsky JE, Boynton KA, et al: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000; 119:1219-1227.
22. Lagerstedt Robinson K, Liu T, Vandrovcova J, et al: Lynch syndrome (hereditary nonpol-yposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007; 99: 291-299.
23. Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B: Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci USA 2003; 100:8817-8822.
24. Diehl F, Schmidt K, Durkee KH, et al: Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 2008; 135: 489-498.
25. Li M, Chen WD, Papadopoulos N, et al: Sensitive digital quantification of DNA methyl-ation in clinical samples. Nat Biotechnol 2009; 27:858-863.
26. Chen WD, Han ZJ, Skoletsky J, et al: Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97:1124 - 1132.